Scribd Logo
Upload

Welcome to Scribd!

  • 143 views

    Oral Antifungal Agents

    Uploaded by

    Indah Febrini Triana Jalal
    This document summarizes several common oral antifungal agents, including their mechanisms of action, therapeutic uses, side effects, and dosages. It discusses azole antifungals like ketoconazole, fluconazole and itraconazole that work by inhibiting ergosterol biosynthesis. Other agents covered include griseofulvin, amphotericin B, terbinafine and flucytosine. These systemic antifungals are used to treat both superficial and systemic fungal infections when topical treatments are not effective. Special considerations for using oral antifungals in pregnancy, liver or kidney disease are also noted.

    Copyright:

    Attribution Non-Commercial (BY-NC)
    Download as PPT, PDF, TXT or read online from Scribd

    Oral Antifungal Agents

    Uploaded by

    Indah Febrini Triana Jalal
    143 views45 pages
    This document summarizes several common oral antifungal agents, including their mechanisms of action, therapeutic uses, side effects, and dosages. It discusses azole antifungals like ketoconazole, fluconazole and itraconazole that work by inhibiting ergosterol biosynthesis. Other agents covered include griseofulvin, amphotericin B, terbinafine and flucytosine. These systemic antifungals are used to treat both superficial and systemic fungal infections when topical treatments are not effective. Special considerations for using oral antifungals in pregnancy, liver or kidney disease are also noted.

    Copyright

    © Attribution Non-Commercial (BY-NC)

    Available Formats

    PPT, PDF, TXT or read online from Scribd

    Did you find this document useful?

    Is this content inappropriate?

    This document summarizes several common oral antifungal agents, including their mechanisms of action, therapeutic uses, side effects, and dosages. It discusses azole antifungals like ketoconazole, fluconazole and itraconazole that work by inhibiting ergosterol biosynthesis. Other agents covered include griseofulvin, amphotericin B, terbinafine and flucytosine. These systemic antifungals are used to treat both superficial and systemic fungal infections when topical treatments are not effective. Special considerations for using oral antifungals in pregnancy, liver or kidney disease are also noted.

    Copyright:

    Attribution Non-Commercial (BY-NC)
    Download as PPT, PDF, TXT or read online from Scribd
    Download as ppt, pdf, or txt
    143 views45 pages

    Oral Antifungal Agents

    Uploaded by

    Indah Febrini Triana Jalal
    This document summarizes several common oral antifungal agents, including their mechanisms of action, therapeutic uses, side effects, and dosages. It discusses azole antifungals like ketoconazole, fluconazole and itraconazole that work by inhibiting ergosterol biosynthesis. Other agents covered include griseofulvin, amphotericin B, terbinafine and flucytosine. These systemic antifungals are used to treat both superficial and systemic fungal infections when topical treatments are not effective. Special considerations for using oral antifungals in pregnancy, liver or kidney disease are also noted.

    Copyright:

    Attribution Non-Commercial (BY-NC)
    Download as PPT, PDF, TXT or read online from Scribd
    Download as ppt, pdf, or txt
    You are on page 1of 45

    ORAL ANTIFUNGAL AGENTS

    AKSA AKBAR KURNIAWATI HATARY SARI IFDIANA JALAL

    INTRODUCTION

    Fungal diseases (mycoses) are chronic infection diseases caused by fungus. Divided into superficial fungal infections and systemic fungal infections.

    ANTIFUNGAL AGENTS Anti fungal agents are drugs that selectively eliminate pathogen fungus from host with minimal toxicity to the host. Divided into 2 major groups : topical agents and systemic agents.

    ORAL ANTIFUNGAL AGENTS Oral antifungal agents are systemic agents used as treatment for superficial, subcutaneous and systemic mycoses.

    AGENTS

    Griseofulvin Azoles (ketoconazole, fluconazole, itraconazole) Amphotericin B Terbinafine Flucytosine

    GRISEOFULVIN MECHANISM OF ACTION : Inhibits nuklease acid and chitin synthesis. Griseofulvin is fungistatic that attached to the new keratin that will resistant to fungus invasion and also inhibits mitosis of fungus.

    Pict. 1 Structure of Griseofulvin

    THERAPEUTIC USES Griseofulvin used as treatment for dermatophytosis and other tinea infection that not responded to other antifungal treatments.

    SIDE EFFECTS Usually mild side effect caused by Griseofulvin such as : - headache - nausea - hypersensitivity reactions like urticaria - skin eruption.

    DOSAGE
    Children : 5-15 mg/kg a day Adult : 500 mg 1 g a day

    AZOLE A broad spectrum antifungal agent that disturb ergosterol biosynthesis, main sterol to keep fungus membrane cell integrity, by inhibit essential enzyme (14-demethylase lanosterol P-450 cytochrome enzyme) in fungus membrane cell ergosterol synthesis.

    KETOCONAZOLE

    Pict. 2 Structure of Ketoconazole

    THERAPEUTIC USES Ketoconazole effective for : - Dermatofitosis - Candidiasis vaginalis - Histoplasmosis - Blastomycosis - Ptyriasis versicolor

    SIDE EFFECTS - Nausea - Anaphylactic - Gynecomastia - Endocrine changes

    DOSAGE Adult : starting dose with 200 mg a day (1 tablet), increased by 400 mg a day if starting dose not responded. Children : 3,3 6,6 mg/kg a day Therapy for 4-6 weeks

    FLUCONAZOLE

    Pict. 3 Structure of Fluconazole

    THERAPEUTIC USES Flukonazole effective for : - Dermatofitosis - Candidiasis (oropharyng, oesophagus, vagina, systemic) - Cryptococcal meningitis

    SIDE EFFECTS - Itching - Edema - Respiratory problem - Hypotension - Diarrhea - Stomachache

    DOSAGE

    Preparation are in tablets 50 mg, 100 mg, 150 mg and 200 mg. Therapeutic doses are 50- 400 mg a day. Candidiasis : 200 mg first day, 100 mg a day for next 2 weeks. Single dose 150 mg for candidiasis vaginalis. Children age above 6 years old : 3-6 mg/kg a day.

    For AIDS patient with cryptococcal meningitis : intial dose as 400 mg a day for 8 weeks, continued with 200 mg a day for a life time.

    ITRACONAZOLE

    Pict. 4 Structure of Itraconazole

    THERAPEUTIC USES Itraconazole effective for : - Blastomikosis - Histoplasmosis - Aspergilosis - Candidiasis - Onikomikosis

    SIDE EFFECTS
    Vomiting Nausea Rash

    Hypokalemia
    Oedema

    Headache

    DOSAGE Therapeutic dose are 2-5 mg/kg a day, maximum dosage are 100-400 mg a day orally. Better use after meal to increase absorption. Onikomikosis : 200 mg a day for 12 weeks Aspergillosis : 200-400 mg a day at least for 3 weeks.

    AMPHOTERICIN B
    A macrocyclic polyene antibiotic derived from Streptomyces nodosus.

    Pict. 5 Structure of Amphotericin B

    MECHANISM OF ACTION Molecules of amphotericin B bind ergosterol in fungus membrane cells cause disturbance of fungus membrane cells and electrolytes that makes cells leakage and death.

    THERAPEUTIC USES Amphotericin B effective for : Life threatening fungus infection and not cured with azoles preparate Fungus such as : Candida spp, Aspergillus spp, Cryptococcus neoformans, Histoplasma capsulatum, Mukormikosis, Fusarium spp,

    Trichosporon beigelii, Sporotrikosis diseminata, Coccidiodes immitis.

    SIDE EFFECTS
    Fever,

    rigidity Anorexia, vomiting, nausea Headache Anaphylactic (1% user) Hypokalemia

    DOSAGE
    Candidiasis : (adult) 100-200 mg x 4 a day (Child) 100 mg x 4 a day Other infection : adult : 0,3-1,0 mg/kg a day. For deep fungal infection, therapy is used for 6-10 weeks.

    TERBINAFINE

    Pict. 6 Structure of Terbinafine

    MECHANISM OF ACTION Inhibition of squalene epoxidase (enzyme of fungus membrane synthesis) that cause ergosterol deficiency and squalene accumulation. Squalene accumulationtoxic to membranemembrane destabilisation (activity of fungisidal)

    Ergosterol deficiencyinhibits growth of fungus cells (activity of fungistatic)

    THERAPEUTIC USES Broad spectrum and actively sensitive to dermatofit. Fungistatic to candida. Effective for fungal nail infection caused by dermatophytes.

    SIDE EFFECTS
    Dyspepsia Nausea Headache

    Skin

    reaction Eruption exanthem (Usually as well tolerated drugs)

    DOSAGE - Preparation is in tablet 125 mg. - 250 mg a day is well responded for dermatophytosis and onychomycosis in 14 days. - Therapy for onychomycosis : 250 mg a day for 6 weeks in finger nail infection and 12 weeks in toe nail.

    For Tinea kapitis therapy based on body weight : 12-18 kg : 62,5 mg (0,5 tablet) 18-25 kg : 125 mg (1 tablet) above 25 kg : 250 mg (2 tablet) a day in 6 weeks.

    FLUCYTOSINE

    Pict 7. Structure of Flucytosine

    MECHANISM OF ACTION Fungistatic : metabolised into fluorouracyl which enter fungus RNA and inhibits protein synthesis and fluorodeoxiuridinmonophosphate which inhibits fungus DNA synthesis.

    THERAPEUTIC USES Candidiasis Cryptococcal disease Severe deep mycoses Chromoblastomycosis subcutan

    SIDE EFFECTS Bone marrow depression and lead to development of leucopenia and trombositopenia Rash Vomiting Nausea Severe enterokolitis

    DOSAGE 37,5 mg/kg a day or maximum dose150 mg/kg a day divided in 4 doses (6 hours duration).

    SPECIAL CONDITION Allergy (Awareness of past experience to drug reaction) Pregnancy (Awareness to baby) Breast-milk feeding (oral antifungal are transferred through breast-milk) Liver disease (systemic antifungal agents are metabolised in liver), renal disease

    CONCLUSION Oral antifungal agents are usually for wide lesion infection and non-responded topical antifungal agent treatment. Special medical condition need attention on oral antifungal agents usage.

    THANK YOU

    You might also like